During the past decade, Szegedi Tudomanyegyetem Szent Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 17 clinical trials were completed, i.e. on average, 73.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 11 clinical trials were completed. i.e. 110% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szegedi Tudomanyegyetem Szent Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar" #1 sponsor was "Amgen" with 7 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Alkahest, Inc." with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szegedi Tudomanyegyetem Szent Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar" #1 collaborator was "HECRIN Consortium" with 2 trials as a collaborator, "Hungarian Ministry of Innovation and Technology" with 2 trials as a collaborator, "Alfasigma S.p.A." with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Szegedi Tudomanyegyetem Szent Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar" are "Arthritis, Psoriatic" (3 trials), "Ulcerative Colitis" (3 trials), "SARS-CoV-2 Infection" (2 trials), "Wet Age-related Macular Degeneration" (2 trials) and "Advanced BRAFV600 Wild-type Melanoma" (1 trials). Many other conditions were trialed in "Szegedi Tudomanyegyetem Szent Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar" in a lesser frequency.

Most popular intervention types in "Szegedi Tudomanyegyetem Szent Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar" are "Drug" (34 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Cyclophosphamide" (3 trials), "Guselkumab" (3 trials), "Rituximab" (3 trials) and "ALK4290" (2 trials). Other intervention names were less common.

The vast majority of trials in "Szegedi Tudomanyegyetem Szent Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar" are 35 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Szegedi Tudomanyegyetem Szent Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Szegedi Tudomanyegyetem Szent Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Szegedi Tudomanyegyetem Szent Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".